The fourth dose: My "me-first" experience
Indian journal of medical ethics, cilt.VII, sa.3, ss.237-239, 2022 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: VII Sayı: 3
- Basım Tarihi: 2022
- Doi Numarası: 10.20529/ijme.2022.010
- Dergi Adı: Indian journal of medical ethics
- Derginin Tarandığı İndeksler: Scopus, EMBASE, MEDLINE, Philosopher's Index
- Sayfa Sayıları: ss.237-239
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Ankara Yıldırım Beyazıt Üniversitesi Adresli: Evet
Özet
Vaccine inequality is the biggest obstacle to curbing the Covid-19 pandemic and accelerating socio-economic recovery in the developing countries. Many people, including myself, living in developing countries, were initially inoculated with the WHO-approved vaccines unwelcome to developed countries, such as Sinovac. Presently, governments in developing countries are offering the third and fourth doses of mRNA vaccines to facilitate cross-border travel. This creates a devastating burden on ongoing Covid-19 vaccination in developing countries, increasing the injustice and inequality between the developed and developing countries. Here, I share my thoughts as a public health specialist while I was receiving the fourth dose of the Covid-19 vaccine to fulfil travel requirements.